Effects of a novel nutraceutical combination (BruMeChol™) in subjects with mild hypercholesterolemia: study protocol of a randomized, double-blind, controlled trial

BACKGROUND: Elevated cholesterol levels and systemic inflammation are considered relevant risk factors for cardiovascular disease (CVD) development and progression. Increasing evidence suggests that cholesterol-lowering and inflammation-lowering nutraceuticals are useful in the management of moderat...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfigli, Anna Rita, Protic, Olga, Olivieri, Fabiola, Montesanto, Alberto, Malatesta, Gelsomina, Di Pillo, Raffaele, Antonicelli, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336431/
https://www.ncbi.nlm.nih.gov/pubmed/32631422
http://dx.doi.org/10.1186/s13063-020-04551-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336431/
https://www.ncbi.nlm.nih.gov/pubmed/32631422
http://dx.doi.org/10.1186/s13063-020-04551-4

Ejemplares similares